Benzinga | May 25, 2021 11:46AM EDT

Humacyte CEO Dr. Laura Niklason Says Vascular Trauma Trial Is Still Underway, Anticipates filing BLA Application Sometime In 2022; If This Were Case, Would Expect First Approval Sometime In 2023

https://www.youtube.com/watch?v=8lbZJjeH2MA